South America Immunodiagnostics Market Forecast to 2028

South America Immunodiagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product [Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others], Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)
Report Code : BMIRE00027836 | Region : LAMEA | Industry : Biotechnology | Published Date : 17/Jan/2023

The South America immunodiagnostics market is expected to grow from US$ 887.91 million in 2022 to US$ 1,399.57 million by 2028; it is estimated to grow at a CAGR of 7.9% from 2022 to 2028.

Increasing Use of Point-of-Care Immunodiagnostics is Driving the South America immunodiagnostics market

Point-of-care testing (POCT) has become critical to patient-centric healthcare due to the need for rapid diagnostic results to determine the accurate and faster treatment. A shift from centralized point-of-care testing to decentralized testing for chronic and infectious patients has resulted in convenient patient access to these diagnostics. Current approach of diagnosis and monitoring chronic conditions or detecting pathogens such as bacteria and viruses rely on immunoassay testing. Advanced point-of-care devices enable rapid screening of up to three components from a single sample. Also, the point-of-care diagnostics (POCD) inclined toward mobile healthcare (mH) smart devices could revolutionize personalized healthcare monitoring and management, paving the way for next-generation POCTs. The infectious disease management can be significantly improved by POCTs, especially in developing countries where access to timely medical care is challenging and healthcare infrastructure is outdated and sparse. Additionally, the technologically developed diagnostic kits leading to fewer manual errors, propel the immunodiagnostics market. Innovative immunodiagnostic products are being developed by several market players. For instance, Thermo Fisher Scientific has developed immunodiagnostic products such as enzyme-linked immunoassay (ELISA) reagents and buffers, antibodies and detection probes, linking mechanisms, blocking buffers and detergents, detection substrates, and capture surfaces, as well as services such as bioconjugation and detection. Further, on September 1, 2020, Roche launched SARS-CoV-2 Rapid Antigen Test. The SARS-CoV-2 Rapid Antigen Test is used in POC settings for symptomatic and asymptomatic people to help healthcare professionals identify the infection within 15 minutes in people suspected of carrying the virus. Likewise, the use of immunodiagnostics in cancer treatment is increasing. In oncology, an immunodiagnostic test can confirm the presence of a solid tumor by detecting known tumor-associated antigens or antibodies. These advantages and indications are driving the South America immunodiagnostics market.

South America Immunodiagnostics Market Overview

The South America immunodiagnostics market is segmented into Brazil, Argentina, and the Rest of SAM. The rising prevalence of infectious diseases and the growing focus on R&D investment and expansion by key players are influencing the market growth in the region. Further, technological advancements in the field of immunodiagnostics are expected to drive the market growth. Additionally, the increasing use of point-of-care immunodiagnostics is expected to create ample opportunities for the growth of the immunodiagnostics market over the forecast period. According to World Population Ageing 2019, in Brazil, the number of people aged above 65 years in 2019 was 19.526 million and is expected to reach 52.026 million by 2050. This rise in the geriatric population is expected to increase the prevalence rate of liver cancer in the country as this population is more prone to chronic diseases, thus boosting the market for immunodiagnostics. Additionally, leukemia is the most common cancer in children and has the incidence rates in industrialized countries, followed by developing countries. As per the GLOBOCAN 2020, 11,396 cases of leukemia were identified in Brazil in 2020, including both males and females of all ages. Such a prevalence indicates the rising demand for acute myeloid leukemia treatment in the country. Thus, the increasing use of point-of-care diagnostics is also majorly contributing to the market growth.

South America Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

South America Immunodiagnostics Market Segmentation

The South America immunodiagnostics market is segmented into product, clinical indication, end user, and country.

Based on product, the South America immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassay (RIA), and others. The enzyme-linked immunosorbent assays (ELISA) segment registered the largest market share in 2022.

Based on clinical indication, the South America immunodiagnostics market is segmented into infectious diseases, hepatitis+HIV, endocrinology, gastrointestinal, metabolics and others. The infectious diseases segment registered the largest market share in 2022.

Based on end user, the South America immunodiagnostics market is segmented into hospitals, clinics, diagnostics laboratories, academic and research institutes, and others. The hospital segment registered the largest market share in 2022.

Based on country, the South America immunodiagnostics market is segmented into Brazil, Argentina, and the Rest of SAM. Brazil dominated the market in 2022.

Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; PerkinElmer Inc.; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthineers AG; Svar Life Science AB; and Thermo Fisher Scientific Inc are the leading companies operating in the South America immunodiagnostics market.

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 South America Immunodiagnostics Market – By Product

1.3.2 South America Immunodiagnostics Market – By Clinical Indication

1.3.3 South America Immunodiagnostics Market – By End User

1.3.4 South America Immunodiagnostics Market– By Country

2. South America Immunodiagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South America Immunodiagnostics Market– Market Landscape

4.1 Overview

4.2 SAM PEST Analysis

4.3 Experts Opinion

5. South America Immunodiagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Infectious Diseases

5.1.2 Growing Use of Point-of-Care Immunodiagnostics

5.2 Market Restraints

5.2.1 Inadequate Reimbursement Scenario

5.3 Market Opportunities

5.3.1 Rising Focus on R&D Investment and Expansion by Key Players

5.4 Future Trends

5.4.1 Technological Advancements in Immunodiagnostics

5.5 Impact Analysis

6. Immunodiagnostics Market– SAM Analysis

6.1 South America Immunodiagnostics Market Revenue Forecast and Analysis

7. South America Immunodiagnostics Market Analysis – by Product

7.1 Overview

7.2 South America Immunodiagnostics Market, By Product, 2021 & 2028 (%)

7.3 Enzyme-linked immunosorbent assays (ELISA)

7.3.1 Overview

7.3.2 Enzyme-linked immunosorbent assays (ELISA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Chemiluminescence immunoassays (CLIA)

7.4.1 Overview

7.4.2 Chemiluminescence immunoassays (CLIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4.3 Vitamin D Assay

7.4.3.1 Overview

7.4.3.2 Vitamin D Assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4.4 HIV Detection

7.4.4.1 Overview

7.4.4.2 HIV Detection: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4.5 HIV Ag/Ab Combo assay

7.4.5.1 Overview

7.4.5.2 HIV Ag/Ab Combo assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4.6 Other Tests

7.4.6.1 Overview

7.4.6.2 Other Tests: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.5 Radioimmunoassays (RIA)

7.5.1 Overview

7.5.2 Radioimmunoassays (RIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. South America Immunodiagnostics Market Analysis – Clinical Indication

8.1 Overview

8.2 South America Immunodiagnostics Market Share by Clinical Indication - 2021 & 2028 (%)

8.3 Infectious Diseases:

8.3.1 Overview

8.3.2 Infectious Diseases: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.3 COVID-19

8.3.3.1 Overview

8.3.3.2 COVID-19: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.4 Tuberculosis

8.3.4.1 Overview

8.3.4.2 Tuberculosis: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.5 Lyme

8.3.5.1 Overview

8.3.5.2 Lyme: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.6 Infection Management

8.3.6.1 Overview

8.3.6.2 Infection Management: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.7 Zika

8.3.7.1 Overview

8.3.7.2 Zika: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.8 Treponema

8.3.8.1 Overview

8.3.8.2 Treponema: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.9 TORCH

8.3.9.1 Overview

8.3.9.2 TORCH: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.10 Measles and Mumps

8.3.10.1 Overview

8.3.10.2 Measles and Mumps: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.11 VZV

8.3.11.1 Overview

8.3.11.2 VZV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.12 EBV

8.3.12.1 Overview

8.3.12.2 EBV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4 Hepatitis+HIV:

8.4.1 Overview

8.4.2 Hepatitis+HIV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.5 Gastrointestinal

8.5.1 Overview

8.5.2 Gastrointestinal: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.6 Metabolics

8.6.1 Overview

8.6.2 Metabolics: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7 Endocrinology

8.7.1 Overview

8.7.2 Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.3 Hypertension

8.7.3.1 Overview

8.7.3.2 Hypertension: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.4 Growth

8.7.4.1 Overview

8.7.4.2 Growth: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.5 Diabetes

8.7.5.1 Overview

8.7.5.2 Diabetes: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.6 Thyroid

8.7.6.1 Overview

8.7.6.2 Thyroid: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.7 Reproductive Endocrinology

8.7.7.1 Overview

8.7.7.2 Reproductive endocrinology: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. South America Immunodiagnostics Market Analysis – End User

9.1 Overview

9.2 South America Immunodiagnostics Market Share by End User - 2021 & 2028 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4 Clinics

9.4.1 Overview

9.4.2 Clinics: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.5 Diagnostic Laboratories

9.5.1 Overview

9.5.2 Diagnostic Laboratories: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.6 Academic and Research Institutes

9.6.1 Overview

9.6.2 Academic and Research Institutes: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

10. South America Immunodiagnostics Market Revenue and Forecast to 2028– by Country

10.1 Overview

10.1.2 SAM: Immunodiagnostics Market, by Country, 2021 & 2028 (%)

10.1.2.1 Brazil: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 Brazil: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 Brazil Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.1 Brazil Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3 Brazil Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3.1 Brazil Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3.2 Brazil Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4 Brazil: Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.2 Argentina: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Argentina: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 Argentina Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.1 Argentina Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3 Argentina Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3.1 Argentina Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3.2 Argentina Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4 Argentina Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.3 Rest of SAM: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 Rest of SAM: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 Rest of South America Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1 Rest of South America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3 Rest of South America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3.1 Rest of South America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3.2 Rest of South America Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4 Rest of South America Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11. South America Immunodiagnostics Market –Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Abbott Laboratories

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 F. Hoffmann-La Roche Ltd

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 DiaSorin S.p.A.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Danaher Corp

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Thermo Fisher Scientific Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 PerkinElmer Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 bioMerieux SA

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Svar Life Science AB

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Siemens Healthineers AG

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. South America Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Table 2. Brazil Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 3. Brazil Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)

Table 4. Brazil Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 5. Brazil Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 6. Brazil Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 7. Brazil Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)

Table 8. Argentina Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 9. Argentina Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)

Table 10. Argentina Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 11. Argentina Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 12. Argentina Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 13. Argentina Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14. Rest of South America Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 15. Rest of South America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)

Table 16. Rest of South America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 17. Rest of South America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 18. Rest of South America Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 19. Rest of South America Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 20. Recent Inorganic Growth Strategies in the Immunodiagnostics Market

Table 21. Recent Organic Growth Strategies in the Immunodiagnostics Market

Table 22. Glossary of Terms, Immunodiagnostics Market

LIST OF FIGURES.

Figure 1. South America Immunodiagnostics Market Segmentation

Figure 2. South America Immunodiagnostics Market Segmentation, By Country

Figure 3. South America Immunodiagnostics Market Overview

Figure 4. South America Immunodiagnostics Market, by Product

Figure 5. South America Immunodiagnostics Market, by Country

Figure 6. South America PEST Analysis

Figure 7. South America Immunodiagnostics Market: Impact Analysis of Drivers and Restraints

Figure 8. South America Immunodiagnostics Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 9. South America Immunodiagnostics Market, by Product, 2021 & 2028 (%)

Figure 10. Enzyme-linked immunosorbent assays (ELISA): South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 11. Chemiluminescence immunoassays (CLIA): South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Vitamin D Assay: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. HIV Detection: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. HIV Ag/Ab Combo assay: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Other Tests: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. Radioimmunoassays (RIA): South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Others: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. South America Immunodiagnostics Market Share by Clinical Indication - 2021 & 2028 (%)

Figure 19. Infectious Diseases: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. COVID-19: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Tuberculosis: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Lyme: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Infection Management: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Zika: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Treponema: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. TORCH: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Measles and Mumps: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. VZV: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29. EBV: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30. Hepatitis+HIV: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 31. Gastrointestinal: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 32. Metabolics: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 33. Endocrinology: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 34. Hypertension: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 35. Growth: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36. Diabetes: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37. Thyroid: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38. Reproductive endocrinology: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39. Others: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 40. South America Immunodiagnostics Market Share by End User - 2021 & 2028 (%)

Figure 41. Hospitals: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 42. Clinics: South America Immunodiagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 43. Diagnostic Laboratories: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 44. Academic and Research Institutes: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 45. Others: South America Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 46. SAM: Immunodiagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 47. SAM: Immunodiagnostics Market, by Country, 2021 & 2028 (%)

Figure 48. Brazil: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 49. Argentina: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 50. Rest of SAM: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

The List of Companies - South America Immunodiagnostics Market

● Abbott Laboratories

● bioMerieux SA

● Danaher Corp

● DiaSorin S.p.A.

● F. Hoffmann-La Roche Ltd

● PerkinElmer Inc.

● Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

● Siemens Healthineers AG

● Svar Life Science AB

● Thermo Fisher Scientific Inc

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America immunodiagnostics market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the South America immunodiagnostics market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth South America market trends and outlook coupled with the factors driving the immunodiagnostics market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Back to Industry Report
Pricing
$3,000.00 Single User Price
$4,000.00 Site Price
$5,000.00 Enterprise Price
Buy Now

Have Additional Questions?

+91 080 43700452 +91 95915 55122 +1 800 2576445
TOP